CYTEMOUNT
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87925965
- Registration number
- 6739618
- Mark type
- Stylized text
- Filed
- 17 May 2018
- Published for opposition
- 16 Oct 2018
- Registered
- 24 May 2022
- Attorney of record
- Gabrielle A. Holley
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for use in the analysis of biological samples for the diagnosis and treatment of cancer, fetal, rare cell, and hematological disorders
Owner
- RareCyte, Inc., Seattle, WA, US
- RareCyte, Inc., Seattle, WA, US
- RareCyte, Inc., Seattle, WA, US
Prior registrations
Prosecution history
- 25 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 21 Apr 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Apr 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Apr 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Dec 2021 — USE AMENDMENT FILED
- 14 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 25 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2021 — SOU EXTENSION 5 GRANTED
- 17 May 2021 — SOU EXTENSION 5 FILED
- 24 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 May 2021 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2020 — SOU EXTENSION 4 GRANTED